การพฒนาสมฤทธผลการดำเนนงานตามนโยบายแกไขบำบดฟนฟผตดยาเสพตดโดยการใชมาตรการลดอนตรายจากยาเสพตดของประเทศไทย (Operation Achievement Development in Accordance to Drug Rehabilitee Policy by Using Harm Reduction Measurement from Drugs of Thailand) [PDF]
Nattawat Takona, Piyakorn Whangmahaporn
openalex
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Machine learning risk prediction models for medication harm in hospitalised adult patients. [PDF]
Lam JYJ +5 more
europepmc +1 more source
Terminology in ecology and evolutionary biology disproportionately harms marginalized groups
Mallory M. Rice +12 more
openalex +2 more sources
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués +3 more
wiley +1 more source
Visual content and thematic analyses of images shared on social media before and after episodes of self-harm in a UK clinical youth sample. [PDF]
Bye A +7 more
europepmc +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
A no‐brainer for ending AIDS: the case for a harm reduction decade
Catherine Cook +2 more
doaj +1 more source

